<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0403256979
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2007
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        LOFRAL 5MG TABLETS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        AMLODIPINE BESILATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        16.2
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="ACINO PHARMA AG" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            ACINO PHARMA AG
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            ACINO PHARMA AG
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C08CA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Lofral tablets (Amlodipine) belongs to a group of medicines called calcium antagonists. Lofral tablets (Amlodipine) are used to treat: - high blood pressure (hypertension) - chest pain due to narrowing of the blood vessels of the heart muscle (angina pectoris) or the more rare form of chest pain caused by cramping of the blood vessels of the heart muscle called Prinzmetal or variant angina. If you suffer from high blood pressure, Amlodipine works by relaxing blood vessels, so that blood passes through them more easily. If you suffer from angina, Amlodipine works by improving blood supply to the heart muscle which then receives more oxygen and as a result chest pain is prevented. Amlodipine does not provide immediate relief of chest pain from angina.&nbsp;<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">a. Do not take Lofral if:&nbsp;<br />&nbsp;<br />- you are hypersensitive to the active substance in the product, to any of the ingredients or to other dihydropyridines.&nbsp;<br />&nbsp;<br />&nbsp;b. Take special care if you&nbsp;<br />&nbsp;<br />- are suffering from other diseases, particularly a liver disease, having any allergies. &nbsp;<br />&nbsp;<br />c. Taking other medicines, herbal or dietary supplements&nbsp;<br />&nbsp;<br />Please tell your doctor or pharmacist if you are taking or externally using any other medicines (including those bought over the counter). &nbsp;<br />&nbsp;<br />d. Taking Lofarl with food and drink &nbsp;<br />&nbsp;<br />Lofral should not be taken together with grapefruit or grapefruit juice, as this can cause an increased fall in blood pressure.&nbsp;<br />&nbsp;<br />e. Pregnancy, breast-feeding &amp; fertility In general, Lofral should not be taken during pregnancy. Tell your doctor if you are pregnant or want to become pregnant. Only your doctor can decide whether in very specific circumstances you may nevertheless take Lofral. Do not breast-feed during treatment with Lofral.&nbsp;<br />&nbsp;<br />f. Driving and using machines Because of its possible side effects, this medicine may affect your reactions and your ability to drive or to use tools or machines.&nbsp;<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Unless directed otherwise by your doctor, you should start by taking one Lofral 5 mg tablet once daily. Your doctor will decide whether you should increase the daily dose to a maximum dose of 10 mg. If you take an overdose of Lofral, you must seek medical attention immediately. Do not change the prescribed dosage of your own accord. If you think the effect of the medicine is too weak or too strong, talk to your doctor or pharmacist.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">The following side effects can occur when taking Lofral: Very common: oedema (accumulation of fluid in the tissues). Common: headache, dizziness, tiredness, drowsiness, nausea, abdominal pain, facial flushing, palpitations. Uncommon: insomnia, mood swings, tremor, taste disorders, fainting, reduced sensitivity to sensory stimuli, abnormal sensations on the skin (tingling), visual disturbances, tinnitus (ringing in the ears), excessively low blood pressure, shortness of breath, runny or blocked nose, vomiting, indigestion, altered bowel habits, dry mouth, hair loss, skin discolouration, increased sweating, skin rash, itching, pain in the joints, muscles and back, muscle cramp,&nbsp;difficulty urinating, increased or night-time urination, erectile dysfunction, breast enlargement, loss of strength, pain, feeling of unwellness, weight gain or loss. Allergic reactions including skin rash, sensitivity to light and swelling of the face have also been reported occasionally. In these cases, stop the treatment and seek medical assistance immediately. Very rare: Muscular stiffness or tension, nerve disorders in the limbs, inflammatory reactions of the small blood vessels, cough, inflammation of the mucous membrane of the stomach, gum overgrowth, liver problems (inflammation of the liver, jaundice) or problems with the pancreas. Frequency not known: There have also been reports of impaired voluntary movement, e.g. associated with increased or decreased muscle tension. You should tell your doctor if you experience these or any other unwanted effects. If you notice any side effects not mentioned in this leaflet, please tell your doctor or pharmacist.&nbsp;<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Store Lofral in the original package. &nbsp;Do not store above 30&deg;C. Keep this medicine out of the reach and sight of children. Do not use Lofral after the date stated on the container after &ldquo;EXP&rdquo;. Your doctor or pharmacist can give you further information. &nbsp;They have the detailed information for healthcare professionals.&nbsp;<br />&nbsp;<br />Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.&nbsp;<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">1 tablet contains 5 mg or 10 mg amlodipine as active substance. The other ingredients are: Cellulose microcrystalline, Calcium hydrogen phosphate, Anhydrous, Sodium starch glycollate, type A, Magnesium stearate.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                 Lofral-5 mg tablets : 
White to off-white round tablets, with “A/5” embossed on break line side. Packs: 30 and 100 tablets. 

Lofral-10 mg tablets:  
White to off-white round tablets, with “A/10” embossed on break line side.   Packs: 30 and 100 tablets.

The tablets are packed in PVC/PVDC/Aluminium blisters.  Not all pack sizes may be marketed.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Manufactured by Acino Pharma AG, Aesch, Switzerland for Acino Pharma AG, Liesberg, Switzerland.&nbsp;<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This package leaflet was last revised in November 2014. 
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">ينتمي&nbsp; لوفرال أقراص (أملوديبين) إلى مجموعة من الأدوية تسُمى مُناهضات الكالسيوم.</p><p dir="RTL">يسُتخَدَم لوفرال أقراص (أملوديبين) لعلاج:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع ضغط الدَّ م (فرط ضغط الدَّ م)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم بالصدر نتيجة تضيق الأوعية الدَّ موية بعضلة القلب (ذبحة صدرية) أو الشكل الأكثر ندرة من ألم الصدر الناجم عن تقلُّ ص الأوعية الدَّ موية لعضلة القلب ويسُمى ذبحة برنزميتال أو الذبحة المخالفة للمعتاد.</p><p dir="RTL">إذا كنت تعُاني من ارتفاع ضغط الدَّ م، فإن أملوديبين يعمل عن طريق إرخاء الأوعية الدَّ موية، بحيث يمر الدَّ م من خلالها بشكل أسهل.</p><p dir="RTL">إذا كنت تعُاني من الذبحة الصدرية، فإن أملوديبين يعمل عن طريق تحسين إمداد عضلة القلب بالدَّ م والتي تحصل بعد ذلك على مزيد من الأكسجين ونتيجة لذلك يتوقف ألم الصدر. لا يقدم أملوديبين تسكين فوري لألم الصدر الناتج عن الذبحة الصدرية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>أ. لا تتناول&nbsp; لوفرال إذا: </strong></p><p>&nbsp;.</p><p dir="RTL">- كنت تعاني من فرط الحساسية تجاه المادة الفعالة في المنتج، أو لأيٍّ من المكونات أو غيرها من الديهيدروبيريدينات.</p><p>&nbsp;</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>ب. توخ حذرًا خاصا:&nbsp; </strong></p><p><strong>&nbsp;</strong></p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - &nbsp;&nbsp; إذا كنت تعاني من أمراض أخرى، َّ وخاصة مرض بالكبد، أو تعاني من أي حساسية.&nbsp;</p><p>&nbsp;</p><p dir="RTL"><strong>&zwnj;ج.&nbsp; </strong><strong>تناول الأدوية الأخرى، المكملات الغذائية أو العشبية </strong></p><p><strong>&nbsp;</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي الخاص بك إذا كنت تتناول أو تستخدم خارجيا أي أدوية أخرى (بما في ذلك تلك التي يتم شراؤها دون وصفة طبية).&nbsp;</p><p>&nbsp;</p><p dir="RTL"><strong>&zwnj;د.&nbsp;&nbsp;&nbsp; </strong><strong>تناوُل&nbsp; لوفرال مع الأطعمة والمشروبات </strong>&nbsp;</p><p><strong>&nbsp;</strong></p><p dir="RTL">لا يجب تناول&nbsp; لوفرال بمصاحبة الجريب فروت أو عصير الجريب فروت؛ إذ قد يسُبب ذلك زيادة الهبوط في ضغط الدَّ م.</p><p>&nbsp;</p><p dir="RTL"><strong>&zwnj;ه.&nbsp;&nbsp;&nbsp; </strong><strong>الحمل والرضاعة الطبيعية والخصوبة </strong></p><p dir="RTL">وبشكل عام، يجب عدم تناول&nbsp; لوفرال خلال فترة الحمل. أخبري طبيبكِ إذا كنتِ حاملًا أو تريدين الحمل. طبيبكِ وحده هو الذي يمكنه أن يقرر ما إذا كان يمكن تناول&nbsp; لوفرال في ظروف محددة للغاية أم لا.</p><p dir="RTL">يجب عليكِ عدم ممارسة الرضاعة الطبيعية أثناء العلاج ب لوفرال.</p><p>&nbsp;</p><p dir="RTL"><strong>&zwnj;و.&nbsp;&nbsp; </strong><strong>القيادة واستخدام الآلات </strong></p><p>نظرًا لآثاره الجانبية المحتملة، قد يؤُثر هذا الدَّ واء على ردود الفعل لديك وعلى قدرتك على ممارسة القيادة أو استخدام الأدوات أو الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يجب عليك البدء عن طريق تناول قرص واحد 5 مجم من&nbsp; لوفرال َّ مر ة واحدة يوميا، ما لم يوجهك طبيبك خلاف ذلك.</p><p dir="RTL">سيقرر طبيبك ما إذا كان يجب عليك زيادة الجرعة اليومية إلى الجرعة القصوى البالغة 10 مجم أم لا.</p><p dir="RTL">إذا تناولت جرعة زائدة من&nbsp; لوفرال، يجب عليك طلب العناية الطبية فورًا.</p><p dir="RTL">لا تغير الجرعة الموصوفة من تلقاء نفسك. إذا شعرت<sup> </sup>أن تأثير الدَّ واء أقوى من اللازم أو أقل من اللازم، فاتصل بطبيبك أو بالصيدلي الخاص بك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">من الممكن حدوث الآثار الجانبية التَّ الية عند تناول&nbsp; لوفرال:</p><p dir="RTL">شائعة جدا: وذمة (تراكُم السائل في الأنسجة).</p><p dir="RTL">شائعة: صداع، دوخة، تعب، نعاس، غثيان، ألم بالبطن، احمرار الوجه، خَفقَان.</p><p dir="RTL">غير شائعة: أرَق، تقلبات الحالة المزاجية، ارتعاش عضلي، اضطرابات بالمذاق، إغماء، انخفاض الحساسية تجاه المؤثرات الحسية، أحاسيس غير طبيعية على الجلد (وخز)، اضطرابات بصرية، طنين بالأذن (رنين في الأذنين)، انخفاض ضغط الد َّم بشكل مفرط، ضيق التَّ نفس، سيلان أو انسداد بالأنف، قيء، عسر الهضم، تغير في طبيعة الأمعاء المعتادة، جفاف الفم ،تساقط الشعر، تغير لون الجلد، زيادة التَّعرق، طفح جلدي، حكة، ألم بالمفاصل والعضلات والظهر، تقلصات عضلية ،صعوبة التَّ بول، زيادة التَّ بول أو التبول أثناء الليل، اضطرابات بالانتصاب، تضخم الثدي، فقدان القوة، ألم، شعور بعدم الارتياح وزيادة أو فقدان الوزن.</p><p dir="RTL">تم الإبلاغ في بعض الأحيان أيضًا عن حدوث تفاعلات حساسية بما في ذلك، طفح جلدي، حساسية تجاه الضوء وتورم بالوجه. في هذه الحالات، قم بإيقاف العلاج واطلب المساعدة الطبية فورًا.</p><p dir="RTL">نادرة جدا: التَّ صلب أو التَّ وتر العضلي، اضطرابات الأعصاب في الأطراف، تفاعلات التهابية بالأوعية الدَّ موية الدقيقة ،سعال، التهاب الغشاء المخاطي بالمعدة، فرط نمو اللثة، مشاكل بالكبد (التهاب الكبد، يرقان) أو مشاكل بالبنكرياس.</p><p dir="RTL">معدل التكرار غير معروف: وردت أيضًا تقارير عن اختلال الحركة الإرادية، على سبيل المثال: المصاحبة لزيادة أو انخفاض التَّ وتر العضلي.</p><p dir="RTL">يجب أن تخبر طبيبك إذا أصبت بهذه الآثار الجانبية أو بأي آثار غير مرغوبة أخرى.</p><p dir="RTL">إذا لاحظت أية آثار جانبية غير المذكورة في هذه النَّ شرة، يرُجى إبلاغ طبيبك أو الصيدلي الخاص بك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ&nbsp; لوفرال داخل العبوة الأصلية.&nbsp;</p><p dir="RTL">لا يخُزن في درجة حرارة تتعدى 30 درجة مئوية.</p><p dir="RTL">احتفظ بهذا الدَّ واء بعيداً عن مُتناوَل ورؤية الأطفال.</p><p dir="RTL">لا تستخدم&nbsp; لوفرال بعد التَّ اريخ المدون على العبوة بعد كلمة &quot;EXP&quot;.</p><p dir="RTL">يمكن لطبيبك أو الصيدلي الخاص بك إمدادك بمعلومات إضافية.&nbsp;</p><p dir="RTL">فهم لديهم معلومات مفصلة لأخصائيي الرعاية الصحية</p><p>&nbsp;</p><p dir="RTL">لا تتخلص من الأدوية عن طريق إلقائها في مياه َّ الصرف أو مع المخلفات المنزلية. استشر الصيدلي الخاص بك عن كيفية التَّ خلص من الأدوية التي لم تعَدُ تستخدمها. ستسُاعد هذه الإجراءات في الحفاظ على البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحتوي القرص الواحد على 5 مجم أو 10 مجم أملوديبين كمادة َّ فعالة.</p><p dir="RTL">المكونات الأخرى هي: سليلوز دقيق التَّبلور، كالسيوم فوسفات الهيدروجين اللا مائي، جليكولات نشا الصوديوم النوع &quot;أ&quot;، ستيرات الماغنسيوم.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><u>لوفرال</u><em>- 5&nbsp;</em><u>مجم أقراص</u></p><p dir="RTL">&nbsp;أقراص دائرية الشكل ذات لون أبيض مائل إلى الأصفر، محفور على جانب خط التَّقسيم&quot;A/5&quot;.</p><p dir="RTL">العبوات: 30 و100 قرص.</p><p dir="RTL"><u>لوفرال</u><em><sub>&nbsp;</sub></em><u><sup>&nbsp;&nbsp;</sup></u><u>10</u><u> مجم أقراص</u>&nbsp;</p><p dir="RTL">أقراص دائرية الشكل ذات لون أبيض مائل إلى الأصفر، محفور على جانب خط التَّقسيم &quot;A/10&quot;.</p><p dir="RTL">العبوات: 30 و100 قرص.</p><p dir="RTL">&nbsp;</p><p dir="RTL">الأقراص مُعبأة في شرائط مصنوعة من بولي فينيل الكلوريد/ بولي فينيليدين الكلوريد/ الألومنيوم.&nbsp;</p><p dir="RTL">قد لا يتم تسويق جميع أحجام العبوات.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تم التَّصنيع عن طريق شركة أسينو فارما إيه جي، آيش، سويسرا لصالح شركة أسينو فارما إيه جي، ليزبيرج، سويسرا.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت آخر مراجعة لنَّ شرة العبوة هذه في نوفمبر 2014. 
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Lofral 5 mg tablets 
Lofral 10 mg tablets 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                 1 Lofral 5 tablet contains: 5 mg amlodipine as 6.94 mg amlodipine besilate.       
1 Lofral 10 tablet contains: 10 mg amlodipine as 13.89 mg amlodipine besilate
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Lofral  5 mg tablets. Pack of 30 tablets 
Lofral 10 mg tablets. Pack of 30 tablets 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">1. Arterial hypertension: Lofral is indicated for the basic treatment of hypertension. Combination therapy may be of advantage in patients who have insufficiently responded to monotherapy. Lofral has been used together with thiazide diuretics, with alpha-blockers, with beta-blockers and with ACE inhibitors. 2. Prophylaxis of attacks in stable angina pectoris which is caused by fixed vasoconstriction. 3. Prinzmetal&rsquo;s or vasospastic angina which is caused by coronary vasospasm. Lofral may be used in those cases where the clinical picture suggests a vasospasm component but this has not been confirmed. Lofral may be administered as monotherapy or in combination with other anti-anginal medicinal products in patients whose angina pectoris does not sufficiently respond to nitrates and/or adequate doses of beta-blockers. N.B.: Lofral is not suitable for treating an acute attack of angina pectoris (attack suppression) because of its slow onset of action.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">For both indications &ndash; hypertension and angina pectoris &ndash; treatment is usually started with a dose of 5 mg Lofral once daily. Depending on the individual response of the patient, the dose may be increased to 10 mg Lofral once daily. An adjustment in the dose of Lofral is not necessary when co-administered with thiazide diuretics, beta-blockers or ACE inhibitors.&nbsp;<br />&nbsp;<br />Special dosage instructions&nbsp;</p><p dir="ltr">Elderly patients Peak plasma concentrations of amlodipine are attained almost at the same time in elderly and young individuals alike. In elderly patients, amlodipine clearance is reduced, which leads on average to an increase in the AUC (area under the concentration-time curve) by about 50% and to an increase in the terminal elimination half-life. The increase in AUC and the prolongation of the terminal elimination half-life in patients with heart failure were as expected for patients in the age group investigated. At comparable doses, amlodipine is equally well tolerated by elderly and young patients. A lower initial dose may therefore be necessary in elderly patients. Children Children and adolescents with hypertension from 6 years to 17 years of age: The recommended antihypertensive oral dose in paediatric patients ages 6-17 years is 2.5 mg once daily as a starting dose, up-titrated to 5 mg once daily if blood pressure goal is not achieved after 4 weeks. Doses in excess of 5 mg daily have not been studied in paediatric patients. For children under 6 years old, no data are available.&rdquo;&nbsp;<br />&nbsp;under 18 years of age. Renal insufficiency In cases of renal insufficiency, Lofral is extensively metabolised to inactive metabolites, and only 10% of the medicinal product is excreted unchanged in the urine. Fluctuations in the plasma amlodipine concentration are not correlated with the degree of renal impairment. Lofral can therefore be administered in normal doses to patients with renal failure. Lofral is not dialysable. Hepatic insufficiency As with all calcium antagonists, the half-life of Lofral is prolonged in hepatic insufficiency. Since there are no dose recommendations for these patients, Lofral should be used with caution in hepatic insufficiency.&nbsp;<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance, dihydropyridines (amlodipine is a dihydropyridine derivative) or to any of the excipients listed in the composition. “severe hypotension - shock (including cardiogenic shock) - obstruction of the outflow tract of the left ventricle (e.g. high grade aortic stenosis) - haemodynamically unstable heart failure after acute myocardial infarction” 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Clinical data available to date regarding administration of Lofral to patients less than 18 years of age are insufficient.&nbsp;</p><p dir="ltr">As with all calcium antagonists, the half-life of Lofral is prolonged in patients with hepatic insufficiency. Since there are no dose recommendations for these patients, Lofral should be used with caution in hepatic insufficiency. Short-acting calcium antagonists of the 1,4-dihydropyridine type with a rapid onset of action are contraindicated in acute myocardial infarction and in the subsequent 30 days as a result of increased mortality. Whether this also applies to treatment with long-acting dihydropyridines with a prolonged onset of action is questionable on the basis of the data currently available. During this period, therefore, the physician should decide on the start of therapy and should monitor patients with particular care at the start of treatment. Use in patients with heart failure In a long-term, placebo-controlled study in patients with NYHA classes III and IV heart failure (without clinical symptoms or objective findings that would indicate an underlying ischaemic disorder), amlodipine had no effect on overall mortality or cardiovascular mortality when administered with stable doses of ACE inhibitors, digitalis and diuretics. Pulmonary oedema occurred significantly more frequently in the same population on amlodipine, although there was no significant difference in the incidence of worsening heart failure compared with placebo.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Other antihypertensives: Lofral may be administered together with thiazide diuretics, alpha-blockers, beta-blockers, ACE inhibitors, long-acting nitrates, sublingual nitroglycerine, non-steroidal anti-inflammatory drugs, antibiotics and oral antidiabetics. Combination treatment may lead to a pronounced decrease in blood pressure due to the synergistic effect of amlodipine and other antihypertensives. Theophylline, ergotamine: Calcium antagonists can interfere with the cytochrome P450-dependent metabolism of theophylline and ergotamine. Since neither in vitro nor in vivo interaction studies have been performed to date with theophylline or ergotamine and amlodipine, it is recommended that the blood concentrations of theophylline or ergotamine be regularly monitored at the start of coadministration. Simvastatin: Repeated use of 10 mg amlodipine in combination with 80 mg simvastatin, compared to simvastatin alone, led to a 77% increase in plasma simvastatin levels. In patients receiving amlodipine, the dose of simvastatin should be limited to 20 mg per day. Grapefruit (juice): The use of amlodipine with grapefruit or grapefruit juice is generally not recommended, as this may increase the bioavailability of amlodipine in some patients and thereby enhance the antihypertensive effect. The reason may be a genetic polymorphism of CYP34A, the principal enzyme responsible for the metabolism of amlodipine. A study in 20 healthy volunteers did not find any significant effect of grapefruit juice on the pharmacokinetics of amlodipine.&nbsp;Special studies: Effects of other active substances on amlodipine Cimetidine: Combined administration of amlodipine and cimetidine does not alter the pharmacokinetics of amlodipine. Aluminium/magnesium (antacids): Co-administration of aluminium/magnesium antacids with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine. Sildenafil: A single dose of sildenafil (100 mg) administered to patients with essential hypertension had no effect on the pharmacokinetic parameters of amlodipine. When amlodipine and sildenafil were administered in combination, each active substance independently exerted its hypotensive effect. CYP3A4 inhibitors: Co-administration of 180 mg diltiazem per day and 5 mg amlodipine in elderly hypertensive patients (69 to 87 years of age) led to a 57% increase in the systemic availability of amlodipine. Co-administration of erythromycin in healthy volunteers (18 to 43 years of age) did not significantly alter the systemic availability of amlodipine (increase in the AUC by 22%). Potent CYP3A4 inhibitors (e.g. ketoconazole, itraconazole, ritonavir) may increase the plasma levels of amlodipine to a greater extent than diltiazem. The clinical relevance of the above-mentioned observations is unclear. However, amlodipine should be used with particular caution in combination with CYP3A4 inhibitors, especially in elderly patients. Clarithromycin: As clarithromycin is a CYP3A4 inhibitor, there is an increased risk of hypotension in patients receiving clarithromycin together with amlodipine. Close patient observation is indicated when amlodipine and clarithromycin are co-administered. CYP3A4 inducers: There are no available data on the effect of CYP3A4 inducers on amlodipine. Combined use of CYP3A4 inducers (e.g. rifampicin, St. John&rsquo;s wort [Hypericum perforatum]) might lead to reduced plasma levels of amlodipine. Amlodipine should therefore be used with caution if coadministered with CYP3A4 inducers. Special studies: Effects of amlodipine on other active substances Atorvastatin: Co-administration of multiple doses of amlodipine (10 mg) with atorvastatin (80 mg) resulted in no significant changes in the steady-state pharmacokinetic parameters of atorvastatin. Digoxin: Studies in healthy volunteers have shown that co-administration of amlodipine with digoxin does not produce any changes in the plasma digoxin level, or in renal digoxin clearance. Ethanol (alcohol): Single and multiple doses of amlodipine (10 mg) had no significant effect on the pharmacokinetics of ethanol. Warfarin: Co-administration of amlodipine and warfarin did not significantly alter the effect of warfarin on the prothrombin time in healthy male subjects. Ciclosporin: No interaction studies of ciclosporin and amlodipine in healthy subjects and in other populations, with the exception of renal transplant patients, have been performed. Various studies in&nbsp;renal transplant patients have shown that co-administration of ciclosporin and amlodipine has different effects on trough ciclosporin concentrations. The effect ranges from the absence of a change to a mean increase of 40%. Particular attention should be paid to ciclosporin levels in renal transplant patients receiving amlodipine. Tacrolimus: With co-administration of amlodipine, there is an increased risk of elevated tacrolimus blood levels. To avoid the toxicity of tacrolimus when administering amlodipine in patients treated with tacrolimus, tacrolimus blood levels must be monitored and the tacrolimus dose adjusted if required. Other: In vitro studies with human plasma show that amlodipine has no effect on protein binding of digoxin, phenytoin, coumarin, warfarin or indometacin.&nbsp;</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">In animal studies, rats treated with amlodipine (at 50 times the maximum recommended human dose) showed delayed onset of parturition and prolonged duration of labour. To date, however, no studies are available on the safe use of Lofral in pregnant and breast-feeding women. Lofral must not be used during pregnancy unless it is absolutely necessary. The fertility of rats was not affected by amlodipine treatment (see &ldquo;Preclinical safety data &ndash; fertility disorders&rdquo;). If Lofral is necessary during lactation, breast-feeding should be discontinued.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Owing to the possibility of undesirable effects, Lofral may impair responsiveness and the ability to drive and use tools and machines.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Amlodipine is well tolerated. Undesirable effects are arranged according to system organ class and frequency using the following definitions: very common (&ge; 1/10); common (&ge; 1/100 to &lt; 1/10); uncommon (&ge; 1/1,000 to &lt; 1/100); rare (&ge; 1/10,000 to &lt; 1/1,000)&nbsp;; very rare (&lt; 1/10,000).&nbsp;<br />&nbsp;<br />Blood and lymphatic system disorders:&nbsp;very rare (&lt; 1/10,000) leukopenia,&nbsp;thrombocytopenia.&nbsp;</p><p dir="ltr">Immune system disorders: very rare (&lt; 1/10,000) allergic reactions.&nbsp;<br />Metabolism and nutrition disorders: very rare (&lt; 1/10,000) hyperglycaemia.&nbsp;<br />Psychiatric disorders : uncommon (&ge; 1/1,000 to &lt; 1/100) insomnia, mood changes.&nbsp;</p><p dir="ltr">Nervous system disorders: common (&ge; 1/100 to &lt; 1/10) dizziness, headache, somnolence. uncommon (&ge; 1/1,000 to &lt; 1/100) tremor, taste disorders, syncope, hypoaesthesia, paraesthesia.&nbsp;very rare (&lt; 1/10,000) increased muscle tone, peripheral neuropathy, Not known: extrapyramidal disorder.&nbsp;<br />&nbsp;Eye disorders: uncommon (&ge; 1/1,000 to &lt; 1/100) visual disturbances. Ear and labyrinth disorders&nbsp;</p><p dir="ltr">Ear Disorders:&nbsp;uncommon (&ge; 1/1,000 to &lt; 1/100) tinnitus. &nbsp;</p><p dir="ltr">Cardiac disorders:&nbsp;common (&ge; 1/100 to &lt; 1/10) palpitations.very rare (&lt; 1/10,000)&nbsp;myocardial infarction, arrhythmia (including bradycardia, ventricular tachycardia and atrial fibrillation), which, however, cannot be&nbsp;differentiated from the natural course of the underlying disease.</p><p dir="ltr">Vascular disorders:&nbsp;common (&ge; 1/100 to &lt; 1/10) facial flushing. uncommon (&ge; 1/1,000 to &lt; 1/100)&nbsp;hypotension.&nbsp;very rare (&lt; 1/10,000) &nbsp;vasculitis.&nbsp;</p><p dir="ltr">Respiratory, thoracic and mediastinal disorders : uncommon (&ge; 1/1,000 to &lt; 1/100) dyspnoea, rhinitis.&nbsp;very rare (&lt; 1/10,000) cough.</p><p dir="ltr">Gastrointestinal disorders:&nbsp;&nbsp;common (&ge; 1/100 to &lt; 1/10) abdominal pain, nausea.&nbsp;<br />uncommon (&ge; 1/1,000 to &lt; 1/100) vomiting, dyspepsia, change in bowel habits, dry mouth.&nbsp;very rare (&lt; 1/10,000) pancreatitis, gastritis, gingival hyperplasia.&nbsp;<br />Hepatobiliary disorders:&nbsp;very rare (&lt; 1/10,000) epatitis, jaundice, elevated liver enzymes (usually accompanied by cholestasis).</p><p dir="ltr">Skin disorders:&nbsp;uncommon (&ge; 1/1,000 to &lt; 1/100)&nbsp;Very rare: angioedema, erythema multiforme, urticaria, exfoliative dermatitis, &nbsp;</p><p dir="ltr">Musculoskeletal disorders:&nbsp;uncommon (&ge; 1/1,000 to &lt; 1/100)&nbsp;arthralgia, myalgia, muscle cramps, back pain.</p><p dir="ltr">Renal and urinary disorders:&nbsp;uncommon (&ge; 1/1,000 to &lt; 1/100) micturition disorders, nocturia,&nbsp;pollakiuria.&nbsp;</p><p dir="ltr">Reproductive system and breast disorders: uncommon (&ge; 1/1,000 to &lt; 1/100) erectile dysfunction, gynaecomastia.&nbsp;<br />&nbsp;&nbsp;<br />General disorders: Very common (&ge; 1/10)&nbsp;oedema (11.1%). Common (&ge; 1/100 to &lt; 1 /10) fatigue. uncommon (&ge; 1/1,000 to &lt; 1/100) asthenia, pain, malaise, chest pain.&nbsp;</p><p dir="ltr">Investigations: uncommon (&ge; 1/1,000 to &lt; 1/100) weight gain, weight loss.&nbsp;&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Available data indicate that a severe overdose can lead to marked peripheral vasodilation and possibly reflex tachycardia. Significant and prolonged systemic hypotension as far as shock with a fatal outcome has been described. Absorption of amlodipine was significantly reduced by the administration of activated charcoal to healthy volunteers immediately or up to two hours after ingestion of 10 mg amlodipine. Gastric lavage may be helpful in some cases and is recommended as one of the usual safety precautions. Clinically relevant hypotension resulting from an Lofral overdose calls for immediate action to support the cardiovascular system: frequent monitoring of cardiac and respiratory function, circulating volume and renal excretion, as well as elevation of the lower extremities. The administration of vasoconstrictive agents can be helpful in supporting vascular tone and blood pressure, provided that vasoconstrictors are not contraindicated. Intravenous calcium gluconate can be helpful for reversing the effect of calcium antagonists. Since Lofral is highly bound to proteins, dialysis can probably not be expected to be of benefit.&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">ATC code: C08CA01 Mechanism of action/Experimental findings (in vitro) Lofral prevents transmembrane influx of calcium ions into myocardial cells and vascular smooth muscle cells, i.e. Lofral is a slow channel blocker and acts as a calcium antagonist. The antihypertensive effect of Lofral is based on a direct relaxant effect on the vascular smooth muscle cells. Clinical efficacy In patients with hypertension, a once-daily dose leads to a clinically significant lowering of blood pressure in both the supine and standing position for 24 h. The onset of effect is slow. Experimental findings The precise mechanism of the anti-ischaemic effect is not yet fully elucidated. It is known that Lofral prevents attacks of angina pectoris in the following two ways: 1. Amlodipine dilates peripheral arterioles and in this way reduces total peripheral resistance (&ldquo;afterload&rdquo;), against which the heart works. Since the heart rate remains stable, this decrease in the load reduces myocardial energy consumption and oxygen demand. 2. The mechanism of action of Lofral probably includes dilation of the major coronary vessels and coronary arterioles, in both healthy and ischaemic areas. This vasodilation improves the oxygen supply to the myocardium in patients with coronary artery spasms (Prinzmetal&rsquo;s or vasospastic angina) and reduces coronary vasoconstriction caused by smoking. In patients with angina, a single daily dose of amlodipine increases total exercise time and prolongs the time to onset of an attack and the time to 1 mm ST segment depression. It also reduces the frequency of attacks and the need for nitroglycerine. Use in patients with heart failure Haemodynamic studies and exercise-based controlled clinical studies in NYHA class II to IV heart failure patients have shown that amlodipine does not lead to clinical deterioration as measured by exercise tolerance, left-ventricular ejection fraction and clinical symptoms (see also &ldquo;Special warnings and precautions for use&rdquo;).&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Independently of food intake, amlodipine is well absorbed after oral administration of therapeutic doses, attaining peak plasma concentrations after 6 to 12 hours. The volume of distribution is&nbsp;approximately 21 l/kg. The terminal plasma half-life is 35-50 hours and permits once-daily dosing. The steady-state concentration is attained after 7-8 days of administration. Amlodipine metabolism is mainly mediated by cytochrome P450 (CYP) 3A4 isoenzymes (major pathway). Amlodipine clearance is low and no clinically relevant interactions have been demonstrated with moderate CYP3A4 inhibitors (diltiazem) or substances that induce metabolism via CYP3A4. No interaction studies with more potent CYP3A4 inhibitors (e.g. ketoconazole, itraconazole or ritonavir) or CYP3A4 inducers (e.g. rifampicin) have been performed. Amlodipine is largely metabolised to inactive metabolites. In the urine, 10% of the substance is excreted in unchanged form and 60% in the form of metabolites. In vitro studies have shown that approximately 97.5% of circulating amlodipine is bound to plasma proteins. In healthy subjects, amlodipine did not significantly influence the effect of co-administered warfarin on the prothrombin time. It can therefore be expected that existing warfarin treatment requires no modification as a result of adding amlodipine. Absolute bioavailability in humans is 64-80%. Use in elderly patients The time to peak plasma concentrations is the same in elderly and young patients. In elderly patients, amlodipine clearance seems to be reduced, leading to an increase in AUC and elimination half-life. The increase in AUC and elimination half-life in patients with chronic heart failure matched expectations with regard to the age group studied (see also &ldquo;Special warnings and precautions for use&rdquo;).</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Carcinogenicity Rats and mice treated with amlodipine in the diet for up to two years at concentrations calculated to provide daily dose levels of 0.5, 1.25 and 2.5 mg/kg/day showed no signs of carcinogenicity. The maximum dose (for mice similar to, and for rats double*, the maximum recommended clinical dose of 10 mg based on mg/m&sup2;) was near to the maximum tolerance dose for mice, but not for rats. Mutagenicity Mutagenicity studies have shown no active substance-related effects either at a gene or chromosome level. Fertility disorders The fertility of rats was not affected by amlodipine treatment (males treated for 64 days and females treated for 14 days before mating) at doses of up to 10 mg/kg/day (8 times* the maximum recommended human dose of 10 mg based on mg/m&sup2;).&nbsp;</p><p dir="ltr">* Based on a patient weighing 50 kg.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Cellulose microcrystalline, Calcium hydrogen phosphate, Anhydrous, Sodium starch glycollate, type A, Magnesium stearate.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Effect on diagnostic methods No known effects.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 Months. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Store in the original package out of the reach and sight of children.</p><p dir="ltr">Climatic zone I and II: &nbsp;Do not store above 25&deg;C.</p><p dir="ltr">Climatic zone III and IV: &nbsp;Do not store above 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Lofral-5 mg tablets White to off-white round tablets, with &ldquo;A/5&rdquo; embossed on break line side and &ldquo;mp&rdquo; on convex side. Lofral-10 mg tablets White to off-white round tablets, with &ldquo;A/10&rdquo; embossed on break line side and &ldquo;mp&rdquo; on convex side. The tablets are packed in PVC/PVDC/Aluminium blisters. Packs of 30 tablets.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Acino Pharma AG, Liesberg, Switzerland. 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                November 2014 
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>